2014 Drug Carriers in Medicine and Biology Gordon Research Conference and Gordon
2014年医学和生物学药物载体戈登研究会议和戈登
基本信息
- 批准号:8717902
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAreaAsiaBasic ScienceBiocompatible MaterialsBiologicalBiologyCanadaChemicalsClinicClinicalCollaborationsConsultationsDataDevelopmentDrug CarriersDrug Delivery SystemsDrug TargetingEngineeringEnvironmentEuropeEye diseasesFacultyFemaleFosteringFundingFunding ApplicantFutureGenderGoalsGrowth and Development functionHeadHealthHumanImageImmunotherapyIn VitroIndustryKnowledgeLocationMedicalMedicineMinority GroupsModelingModern MedicineModificationMolecularNatureNew HampshireOrganismPatientsPersonsPharmaceutical PreparationsPharmacologic SubstancePolymer ChemistryPolymersPopulationPostdoctoral FellowProteinsResearchResearch PersonnelResearch PriorityResortScienceScientistSeasonsSmall Interfering RNASolubilityStagingStudentsSystemTestingTherapeuticTherapeutic EffectTimeTrainingTranslationsUnderrepresented MinorityVaccinesWomanWorkabstractingcancer immunotherapycancer therapycareerclinical applicationdesignenzyme therapygraduate studentimaging probeimprovedin vivoinsightmedical specialtiesmeetingsmolecular imagingmultidisciplinarynovelnovel strategiespatient orientedpostersprofessorprogramsprospectivepublic health relevancesmall moleculesymposiumtargeted deliverytraffickinguptakeworking group
项目摘要
DESCRIPTION (provided by applicant): Funding is requested for partial support of the Gordon Research Conference and associated Gordon Research Symposium on Drug Carriers in Medicine and Biology to be held in Waterville Valley Resort, New Hampshire August 16-22, 2014. This comprehensive meeting will focus on cutting edge research in drug delivery, while simultaneously providing an outstanding forum for junior and senior researchers, students and postdocs from academia and industry to engage each other. The long term goals are to foster collaboration to bring the field to an even higher level, support the growth and development of young researchers in order to increase the worker pipeline in this important topic, and to provide an avenue for translation of cutting edge research to the clinic and patients. Drug delivery is a crucial component of modern day medicine, and the design and optimization of targeted drug carriers is an important area of research. The subtopic of the GRC is "Leveraging Mechanism and Chemical Design for Improved Therapeutic Effect" and the GRS is " Molecular and Cellular." In particular, the conference will focus on the latest delivery systems and include sessions on mechanisms of carrier distribution, cellular uptake and trafficking, and new approaches to addressing hurdles. Session themes include targeted systems for delivery, new approaches to chemical modification, engineering, and conjugation for improved delivery, and transport, fate, and efficacy of drug delivery systems. Applications and exciting opportunities in ophthalmic delivery, cancer, and immunotherapy will be included in specific sessions. Clinical opportunities and translation will be a key focus of the meeting, with industrial participation to give this perspective. Speakers and discussion leaders are recognized leaders in their fields and were chosen in consultation with scientists who represent the breadth of the field of drug delivery. The GRC/GRS program reflects diversity in the population in terms of gender, career stage, location, and underrepresented minority group. In particular, this high quality program will
include talks from early career stages (graduate students and postdocs for the GRS and assistant and associate professors and young industrial researchers for the GRC), from persons of underrepresented groups, and females. Diversity will be further boosted through active recruitment and registration of faculty and trainees from underrepresented groups. This proposal seeks funding specifically for this goal. The specific objectives of the Engineering Advances in Drug Targeting GRC/GRS are: 1) To provide a forum for discussion of the latest drug carrier research. 2) To bring together a diverse group of scientists working in different areas of drug delivery design. 3) To identify priority research themes for the coming years by identifying gaps in knowledge and improving conceptual models. 4) To provide a high quality and accessible arena for interaction between trainees and senior researchers. 5) To provide an avenue for young researchers to give talks and posters and to broaden their training for their future careers.
描述(由申请人提供):资金要求部分支持戈登研究会议和相关的戈登研究研讨会药物载体在医学和生物学将在沃特维尔谷度假村,新罕布什尔州2014年8月16日至22日举行。这次全面的会议将重点关注药物输送的前沿研究,同时为来自学术界和工业界的初级和高级研究人员,学生和博士后提供一个优秀的论坛。长期目标是促进合作,使该领域达到更高的水平,支持年轻研究人员的成长和发展,以增加这一重要课题的工作人员队伍,并为将尖端研究转化为临床和患者提供途径。药物传递是现代医学的重要组成部分,靶向药物载体的设计和优化是一个重要的研究领域。GRC的子主题是“利用机制和化学设计改善治疗效果”,GRS是“分子和细胞”。“特别是,会议将侧重于最新的交付系统,并包括关于载体分配机制,细胞吸收和贩运以及解决障碍的新方法的会议。会议的主题包括有针对性的系统交付,新的化学修饰方法,工程和共轭改善交付,运输,命运和药物输送系统的功效。在眼科输送,癌症和免疫治疗的应用和令人兴奋的机会将包括在特定的会议。临床机会和翻译将是会议的重点,工业界的参与将提供这一视角。演讲者和讨论领导者是各自领域公认的领导者,并与代表药物输送领域广度的科学家协商选择。GRC/GRS计划反映了人口在性别,职业阶段,位置和代表性不足的少数群体方面的多样性。特别是,这一高质量的计划将
包括从职业生涯早期阶段(研究生和博士后的研究生和研究生院的助理和副教授和年轻的工业研究人员的GRC),从代表性不足的群体的人,和女性的谈话。通过积极招聘和登记来自代表性不足群体的教师和学员,将进一步促进多样性。本提案寻求专门为此目标提供资金。药物靶向工程进展GRC/GRS的具体目标是:1)提供一个讨论最新药物载体研究的论坛。2)汇集了在药物输送设计的不同领域工作的不同科学家。3)通过确定知识差距和改进概念模型,确定未来几年的优先研究主题。4)为学员和高级研究人员提供一个高质量和可访问的竞技场。5)为青年研究人员提供一个演讲和海报的渠道,并为他们未来的职业生涯提供更广泛的培训。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heather D Maynard其他文献
Heather D Maynard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heather D Maynard', 18)}}的其他基金
Stabilization of Glucagon by Trehalose Gylcopolymer Nanogels
海藻糖乙二醇聚合物纳米凝胶对胰高血糖素的稳定性
- 批准号:
10558471 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Stabilization of Glucagon by Trehalose Gylcopolymer Nanogels
海藻糖乙二醇聚合物纳米凝胶对胰高血糖素的稳定性
- 批准号:
10372210 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Trehalose Glycopolymers to Enhance both Pharmacokinetics and Stability of Therapeutic Proteins
海藻糖糖聚合物可增强治疗性蛋白质的药代动力学和稳定性
- 批准号:
9113714 - 财政年份:2016
- 资助金额:
$ 1.5万 - 项目类别:
Trehalose Glycopolymers to Enhance both Pharmacokinetics and Stability of Therapeutic Proteins
海藻糖糖聚合物可增强治疗性蛋白质的药代动力学和稳定性
- 批准号:
9245687 - 财政年份:2016
- 资助金额:
$ 1.5万 - 项目类别:
Stable and Active bFGF-Polymer Conjugates for Wound Healing
用于伤口愈合的稳定且活性强的 bFGF-聚合物缀合物
- 批准号:
8246214 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Stable and Active bFGF-Polymer Conjugates for Wound Healing
用于伤口愈合的稳定且活性强的 bFGF-聚合物缀合物
- 批准号:
8588251 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Stable and Active bFGF-Polymer Conjugates for Wound Healing
用于伤口愈合的稳定且活性强的 bFGF-聚合物缀合物
- 批准号:
8776294 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Stable and Active bFGF-Polymer Conjugates for Wound Healing
用于伤口愈合的稳定且活性强的 bFGF-聚合物缀合物
- 批准号:
8398914 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 1.5万 - 项目类别:
Research Grant